ADVANCES IN CHEMOTHERAPY IN ONCO-HEMATOLOGY

被引：0
|
作者：
MARTY, M [1 ]
GISSELBRECHT, C [1 ]
JACQUILLAT, C [1 ]
BOIRON, M [1 ]
机构：
[1] HOP ST LOUIS,LEUCEMIES & MALAD SANG RECH INST,F-75475 PARIS 10,FRANCE
来源：
NOUVELLE REVUE FRANCAISE D HEMATOLOGIE | 1980年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：R6 / R6
页数：1
相关论文
共 50 条
  • [41] Microsatellite Typing of Aspergillus flavus Strains in a Tunisian Onco-hematology Unit
    Soukeina Gheith
    Fatma Saghrouni
    Anne-Cécile Normand
    Wadiaa Bannour
    Abderrahim Khelif
    Renaud Piarroux
    Moncef Ben Said
    Mansour Njah
    Stéphane Ranque
    Mycopathologia, 2016, 181 : 175 - 184
  • [42] Retinoids in Pediatric Onco-Hematology: the Model of Acute Promyelocytic Leukemia and Neuroblastoma
    Masetti, Riccardo
    Biagi, Carlotta
    Zama, Daniele
    Vendemini, Francesca
    Martoni, Anna
    Morello, William
    Gasperini, Pietro
    Pession, Andrea
    ADVANCES IN THERAPY, 2012, 29 (09) : 747 - 762
  • [43] Microsatellite Typing of Aspergillus flavus Strains in a Tunisian Onco-hematology Unit
    Gheith, Soukeina
    Saghrouni, Fatma
    Normand, Anne-Cecile
    Bannour, Wadiaa
    Khelif, Abderrahim
    Piarroux, Renaud
    Ben Said, Moncef
    Njah, Mansour
    Ranque, Stephane
    MYCOPATHOLOGIA, 2016, 181 (3-4) : 175 - 184
  • [44] DETECTION OF MINIMAL RESIDUAL DISEASE IN ONCO-HEMATOLOGY AND MOLECULAR-BIOLOGY
    HENNI, T
    VIDAUD, M
    BRETAGNE, S
    GOOSSENS, M
    PATHOLOGIE BIOLOGIE, 1988, 36 (01): : 91 - 95
  • [45] Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology
    Crisci, Stefania
    Amitrano, Filomena
    Saggese, Mariangela
    Muto, Tommaso
    Sarno, Sabrina
    Mele, Sara
    Vitale, Pasquale
    Ronga, Giuseppina
    Berretta, Massimiliano
    Di Francia, Raffaele
    MEDICINA-LITHUANIA, 2019, 55 (08):
  • [46] Innovative cell-based therapies in onco-hematology: what are the clinical facts?
    Introna, M
    Barbui, AM
    Golay, J
    Rambaldi, A
    HAEMATOLOGICA, 2004, 89 (10) : 1253 - 1260
  • [47] Analysis of the approach to risk management in onco-hematology centers: results of a survey in Italy
    Farina, Massimo
    De Paoli, Gianni
    Canciani, Monica
    TUMORI, 2016, 102 : S7 - S14
  • [48] Patterns of use and safety of ibrutinib in real-life practice in onco-hematology
    Allouchery, M.
    Perault-Pochat, M. C.
    Salvo, F.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2024, 38 : 43 - 43
  • [49] CLINICAL-APPLICATIONS OF HEMATOPOIETIC COLONY-STIMULATING FACTORS IN ONCO-HEMATOLOGY
    TIGAUD, JD
    BASTION, Y
    COIFFIER, B
    M S-MEDECINE SCIENCES, 1991, 7 (05): : 444 - 452
  • [50] MULTIDRUG-RESISTANCE - MECHANISM, BIOLOGICAL DETECTION AND INTEREST IN CLINICAL ONCO-HEMATOLOGY
    GUERCI, AP
    REVUE DE MEDECINE INTERNE, 1993, 14 (08): : 772 - 779
12345